Prabu Nambiar, PhD, MBA, RAC
Founder, Syner-G BioPharma Group
Prior to founding Syner-G in 2010, Prabu held senior Regulatory positions at Aveo Oncology, Vertex, Cubist, Wyeth, Sepracor, and BMS. He then created Syner-G with a vision to provide customized, science-based CMC regulatory solutions for complex CMC Regulatory/Quality issues for development and post-approval products. Prabu is a member of the AAPS, ACS, and RAPS Societies; he also served as a Physical Analysis Expert Council Member and Chair of the Organic Impurities Expert Panel at the U.S. Pharmacopeia from 2010-2020.